
Repro Med Systems KRMD
$ 6.25
-3.55%
Quarterly report 2025-Q3
added 11-12-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
45.6 M |
Market Cap[1] |
$ 285 M |
EBITDA (LTM) |
$ -3.27 M |
P/E (LTM) |
324.0 |
P/S (LTM) |
7.69 |
EPS (LTM) |
0.02 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
$ 19.32 | 1.05 % | $ 9.85 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 196.18 | -0.01 % | $ 56.4 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 5.47 | -0.01 % | $ 110 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.71 | -1.78 % | $ 30.1 M | Nasdaq Global Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Alcon
ALC
|
$ 80.33 | 0.26 % | $ 40.4 B | NYSE | ||
|
iRhythm Technologies
IRTC
|
$ 177.0 | 0.68 % | $ 5.52 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 148.17 | 0.81 % | $ 3.61 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 83.95 | -0.46 % | $ 1.88 B | Nasdaq Global Market,SPB | ||
|
AtriCure
ATRC
|
$ 40.7 | 0.37 % | $ 1.91 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.93 | 1.54 % | $ 27.2 K | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 13.12 | -0.3 % | $ 536 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 87.36 | -0.03 % | $ 5.09 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 82.55 | -0.03 % | $ 16.4 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 116.08 | -0.56 % | $ 5.62 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 80.39 | 0.36 % | $ 4.05 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.93 | -1.71 % | $ 184 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 132.7 | -0.44 % | $ 7.07 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.43 | - | $ 181 M | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 578.08 | 0.16 % | $ 205 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.16 | -0.88 % | $ 22 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | -1.41 % | $ 23.1 M | NYSE American | ||
|
Nephros
NEPH
|
$ 4.98 | -4.78 % | $ 51.7 M | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 255.64 | 0.02 % | $ 25.2 B | NYSE,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 21.99 | -0.05 % | $ 3.79 B | NYSE | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pro-Dex
PDEX
|
$ 39.33 | -2.65 % | $ 129 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 56.66 | 0.66 % | $ 206 M | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 14.45 | -2.76 % | $ 694 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 245.14 | 0.3 % | $ 35.8 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.47 | 3.66 % | $ 2.33 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 165.37 | -0.18 % | $ 9.21 M | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 24.95 | -1.81 % | $ 1.15 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.46 | 1.23 % | $ 199 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.37 | -1.1 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.82 | -0.51 % | $ 24.5 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 122.75 | 0.7 % | $ 5.75 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 274.28 | -0.95 % | $ 20 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.